Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Group 1 Automotive Adds Conifer-Backed Director to Board

Group 1 Automotive, Inc. filed a Form 8-K on September 22, 2026, disclosing that it entered into a Stockholder Agreement with Conifer Management, L.L.C. on September 21, 2026, and appointed Benjamin Hart to its Board of Directors effective November 1, 2026.

Aakashdeep | 22 September 2026

Celldex Therapeutics Reports Phase 3 CSU Trial Results

Celldex Therapeutics, Inc. filed a Form 8-K on September 22, 2026, announcing results from its two Phase 3 EMBARQ-CSU1 and EMBARQ-CSU2 trials of Barzolvolimab in chronic spontaneous urticaria (CSU).

Aakashdeep | 22 September 2026

Willis Lease Finance Plans $35M Series B Preferred Stock Sale

Willis Lease Finance Corporation filed a Form 8-K on September 22, 2026, disclosing a private placement agreement to issue 1,750,000 shares of newly created Series B Preferred Stock to the Development Bank of Japan Inc. at $20.00 per share, with expected gross proceeds of …

Aditi Sarkar | 22 September 2026

Beam Global Eyes European Drone Tech Acquisition

Beam Global filed a Form 8-K on September 22, 2026, disclosing that it entered into a non-binding letter of intent relating to the proposed acquisition of a European drone technology company.

Anjali Anand | 22 September 2026

Contango Silver & Gold Files 8-K on Kitsault Valley Technical Report

Contango Silver & Gold Inc. filed a Current Report on Form 8-K with the SEC on September 22, 2026, disclosing the completion of a Technical Report Summary for its Kitsault Valley Project and furnishing a new corporate presentation under Regulation FD.

Aditi Sarkar | 22 September 2026

Knightscope Reports ~$27M in Renewals and Bookings

Knightscope, Inc. filed a Form 8-K with the SEC on September 22, 2026, disclosing approximately $27 million in estimated renewals, bookings, and client awards for the period May 20, 2026 through September 18, 2026.

Vinay Lochav | 22 September 2026

Fiserv Chief Legal Officer Transition Announced

Fiserv, Inc. filed a current report on Form 8-K on September 22, 2026, disclosing the resignation of its Chief Administrative Officer and Chief Legal Officer and the appointment of a successor Chief Legal Officer.

Manish Choudhary | 22 September 2026

Jersey Mike's Subs Discloses Blackstone Margin Loan Pledge

Jersey Mike's Subs Inc. filed an 8-K on September 22, 2026, disclosing that Blackstone affiliates pledged a combined 172,621,820 shares of company stock and 44,990,370 common units as collateral for margin loan agreements totaling approximately $1.09 billion, with Morgan Stanley Senior Funding, Inc. serving …

Nitish Kishor | 22 September 2026

Filana Therapeutics FDA Clinical Hold on Simufilam Lifted

Filana Therapeutics, Inc. filed a Form 8-K on September 22, 2026, disclosing that the U.S. Food and Drug Administration lifted the full clinical hold on its investigational new drug application for simufilam in tuberous sclerosis complex-related epilepsy.

Anjali Anand | 22 September 2026

PDS Biotechnology Announces JAMA Oncology Publication of VERSATILE-002 Phase 2 Trial Results

PDS Biotechnology Corporation filed a Form 8-K on September 22, 2026, disclosing a press release announcing the publication of Phase 2 trial results for its HPV16-targeted immunotherapy PDS0101 in combination with pembrolizumab in the September 17, 2026, issue of JAMA Oncology.

Shwetambri Chauhan | 22 September 2026
Support

Hi! How can we help you today?

Loading…